Tempus receives FDA clearance for updated cardiac imaging device

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/12/2026

1. SKHY
2. USO
3. SPY
4. META
5. DAL
6. PEP
7. ALP
8. SKHYV
9. NVDA
10. NRIX

Go back to Tempus receives FDA clearance for updated cardiac imaging device
StemCells, Inc. (NASDAQ: TEM) Delayed: 58.23 -3.27 (5.32%)
Previous Close $61.50    52 Week High $0.45 
Open $62.75    52 Week Low $0.37 
Day High $62.95    P/E N/A 
Day Low $57.45    EPS $-0.31 
Volume 4,385,259